Humana Inc. $HUM Shares Bought by Prime Capital Investment Advisors LLC

Prime Capital Investment Advisors LLC raised its stake in Humana Inc. (NYSE:HUM) by 10.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 953 shares of the insurance provider’s stock after buying an additional 91 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Humana were worth $233,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of HUM. Revolve Wealth Partners LLC acquired a new position in Humana in the fourth quarter valued at about $202,000. GAMMA Investing LLC lifted its position in shares of Humana by 54.9% during the first quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider’s stock worth $781,000 after purchasing an additional 1,046 shares in the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Humana by 8.2% during the first quarter. Assenagon Asset Management S.A. now owns 5,378 shares of the insurance provider’s stock worth $1,423,000 after purchasing an additional 409 shares in the last quarter. CX Institutional acquired a new stake in shares of Humana during the first quarter worth about $213,000. Finally, Fifth Third Bancorp lifted its position in shares of Humana by 14.4% during the first quarter. Fifth Third Bancorp now owns 8,228 shares of the insurance provider’s stock worth $2,177,000 after purchasing an additional 1,034 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on HUM. Morgan Stanley reduced their price target on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 31st. Bank of America increased their price target on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research report on Friday. Piper Sandler reduced their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research report on Thursday, July 31st. Mizuho increased their price target on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Wall Street Zen cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Eight investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus target price of $298.83.

Humana Stock Down 3.6%

Shares of Humana stock opened at $280.24 on Monday. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35. The company has a 50 day moving average of $279.45 and a 200 day moving average of $258.04. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $33.71 billion, a P/E ratio of 21.51, a P/E/G ratio of 1.64 and a beta of 0.42.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana’s dividend payout ratio is currently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.